• Home
  • Research areas
    • ADME-Tox
    • Biomarkers
    • Cell Biology and Signalling
    • Cell Sourcing – Cell Culture Technologies
    • Drug Discovery
    • Gene Expression – Molecular Biology
    • Stem Cells
    • Supplying Discovery Tools
  • Contact us
  • Meet the authors
  • Facebook
  • Google+
  • LinkedIn
  • Twitter
  • YouTube
Home
Research areas
    ADME-Tox
    Biomarkers
    Cell Biology and Signalling
    Cell Sourcing - Cell Culture Technologies
    Drug Discovery
    Gene Expression - Molecular Biology
    Stem Cells
    Supplying Discovery Tools
Contact us
Meet the authors
tebu-bio's blog - Acting and reacting in life sciences and biotechnologies
  • Home
  • Research areas
    • ADME-Tox
    • Biomarkers
    • Cell Biology and Signalling
    • Cell Sourcing – Cell Culture Technologies
    • Drug Discovery
    • Gene Expression – Molecular Biology
    • Stem Cells
    • Supplying Discovery Tools
  • Contact us
  • Meet the authors
Supplying Discovery Tools

CAR T-Cell therapy: new hope for Immunotherapy and Cancer treatment

05/11/2018 by Frédéric Samazan No Comments

Personalized treatment for cancer reached a new milestone with the FDA approval of CAR T-cells for treatment of leukemia and lymphoma.  There is now rapid growth in research on the therapeutic uses of CAR T-cells.

To help researchers develop efficient CAR T-cells, we aim to provide many innovative solutions, such as recombinant cell line expressing cancer antigens, or recombinant versions of these antigens. Developed by BPS Bioscience, these products will help scientists to more precisely monitor the effectiveness of the engineered CAR T to detect and bind to a specific cancer antigen.

Continue reading
Supplying Discovery Tools

HDACs: Active drug targets for Immunotherapy treatment

13/06/2018 by Frédéric Samazan No Comments

For many pathologies such as cancer or neurological disorders, it has been found that Histone Deacetylase (HDAC) activity is disrupted, making them promising targets for drug development. Scientists need access to a broade range of products ( Active Enzyme, inhibitors/activators, Biochemical screening assays…), to simplify their research and identification of HDAC inhibitors.

Continue reading
News

AIM Biochips – 3D cell culture platform for Immunotherapy and T Cell therapy studies

18/05/2018 by Frédéric Samazan No Comments

As mentioned in a previous post the DAX Biochips from AIM Biotech are an innovative and versatile microfluidic platform, allowing researchers to more easily develop 3D cell culture models, to work as close as possible to what occurs in the human body, but under in-vitro conditions.

Due to its innovative structure (as seen in this general AIM Chips flyer), a broad range of applications have already been validated on this model (Cellular Migration-Invasion Analysis / Angiogenesis studies / Metstasis Modeling System), but what’s new is that now Immunotherapy and T-Cell Therapy studies can be performed on this technology.

Continue reading
Cell Biology and Signalling

TIGIT – Promising target to restore immune response

25/01/2018 by Frédéric Samazan No Comments
immune inhibition and activation

TIGIT:CD155/CD112 immune inhibition (in green)

Over the last several years, the Immune System has appeared as a central, priority target to fight cancer and various other diseases. Currently, in cancer treatment most of the Immunotherapeutic successes, are molecules developed to modulate and restore immune response by targeting critical Immune Checkpoints.

Some of them can activate T Cells, and on the opposite, some can inhibit this response against cancer cells, such as PD-1 and CTLA4, two of the most studied Immune Checkpoints. The majority of the popular molecules approved in Immunotherapy which have led to clinical benefits, are antibodies inhibiting immune checkpoint activities, such for PD1 with nivolumab and pembrolizumab, or CTLA4 with ipilumab.

Continue reading
Page 1 of 61234»...Last »
tebu-bio

LAB SERVICES OUTSOURCING

• Protein production

• Plasmid Preps

• 3D Cell Culture
LEARN MORE

Most popular posts

  • HeLa cells: Origin of this important cell line in life science research
  • From RUO to IVD - the acronym guide to reagents' intended use
  • How to choose the perfect buffer to get a pure, stabilised, functional protein
  • Differentiate between Apoptosis, Necroptosis, Autophagy & Ferroptosis
  • Differentiate between K48- and K63-specific Ubiquitination
My Tweets

Top contributors

Dimitri Szymczak, PhD
Dimitri Szymczak, PhD
  • New ATM and ATR inhibitor biomarker – How to study key sensors of DNA damage
  • Get closer to the real Host Cell Protein (HCP) quantity
Frédéric Samazan
Frédéric Samazan
  • Lympholyte®: The ideal tool for simple and viable lymphocytes isolation
  • CAR T-Cell therapy: new hope for Immunotherapy and Cancer treatment
Isabelle Nobiron
Isabelle Nobiron
  • Proteomics Biostats: get the most out of your array data
  • Hepatic Hyaluronan Content increased by Alcohol Consumption in Patients with Liver Steatosis
Isabelle Topin, PhD
Isabelle Topin, PhD
  • Monoclonal antibodies – all you need to know about antibody generation
  • Tips and Tricks: how to increase unstable protein expression in E. Coli
Philippe Fixe, PhD
Philippe Fixe, PhD
  • 10 Human Immune Checkpoint biomarkers quantified simultaneously
  • 3D cell culture: discover the new VitroGel™ 3D Hydrogel system

Copyright © 2018 - tebu-bio - visit our main website at tebu-bio.com